As of 2024-12-14, the Relative Valuation of FibroGen Inc (FGEN) is (32.51) USD. This relative valuation is based on P/E multiples. With the latest stock price at 0.33 USD, the upside of FibroGen Inc based on Relative Valuation is -9866.3%.
The range of the Relative Valuation is (33.31) - (34.28) USD.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| Trailing P/E multiples | 27.6x - 40.2x | 34.4x |
| Forward P/E multiples | 19.0x - 28.4x | 19.4x |
| Fair Price | (33.31) - (34.28) | (32.51) |
| Upside | -10105.9% - -10396.4% | -9866.3% |
| Date | P/E |
| 2024-12-13 | -0.28 |
| 2024-12-12 | -0.28 |
| 2024-12-11 | -0.29 |
| 2024-12-10 | -0.30 |
| 2024-12-09 | -0.30 |
| 2024-12-06 | -0.28 |
| 2024-12-05 | -0.34 |
| 2024-12-04 | -0.34 |
| 2024-12-03 | -0.34 |
| 2024-12-02 | -0.35 |
| 2024-11-29 | -0.35 |
| 2024-11-27 | -0.32 |
| 2024-11-26 | -0.32 |
| 2024-11-25 | -0.32 |
| 2024-11-22 | -0.33 |
| 2024-11-21 | -0.32 |
| 2024-11-20 | -0.29 |
| 2024-11-19 | -0.29 |
| 2024-11-18 | -0.28 |
| 2024-11-15 | -0.28 |
| 2024-11-14 | -0.31 |
| 2024-11-13 | -0.27 |
| 2024-11-12 | -0.32 |
| 2024-11-11 | -0.28 |
| 2024-11-08 | -0.27 |
| 2024-11-07 | -0.26 |
| 2024-11-06 | -0.26 |
| 2024-11-05 | -0.25 |
| 2024-11-04 | -0.27 |
| 2024-11-01 | -0.26 |
| 2024-10-31 | -0.25 |
| 2024-10-30 | -0.26 |
| 2024-10-29 | -0.25 |
| 2024-10-28 | -0.25 |
| 2024-10-25 | -0.25 |
| 2024-10-24 | -0.26 |
| 2024-10-23 | -0.26 |
| 2024-10-22 | -0.29 |
| 2024-10-21 | -0.31 |
| 2024-10-18 | -0.32 |
| 2024-10-17 | -0.33 |
| 2024-10-16 | -0.31 |
| 2024-10-15 | -0.29 |
| 2024-10-14 | -0.28 |
| 2024-10-11 | -0.30 |
| 2024-10-10 | -0.28 |
| 2024-10-09 | -0.27 |
| 2024-10-08 | -0.27 |
| 2024-10-07 | -0.28 |
| 2024-10-04 | -0.30 |